Enoxaparin Versus Tinzaparin for Venous Thromboembolic Prophylaxis During Rehabilitation After Acute Spinal Cord Injury: A Retrospective Cohort Study Comparing Safety and Efficacy
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To compare the safety and efficacy of 3 low-molecular-weight heparin (LMWH) treatments
(enoxaparin, 40 mg once daily, with an alternative LMWH, tinzaparin, 3500 or 4500
units once daily) for the prevention of venous thromboembolic events (VTEs) after
acute spinal cord injury (SCI).